Holliday Keith

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$12.57M

Insider Activity of Holliday Keith

The largest sale of all time was on 2021-03-01 and amounted to 18991 share of STAAR Surgical Company for $1.99M.

Biography of Holliday Keith

No biography is available at this moment.

2023-03-17SaleSTAAR Surgical Company
STAA
Chief Technology Officer
823
0.0018%
$61.97$51,001-29.62%
2022-08-15SaleSTAAR Surgical Company
STAA
Chief Technology Officer
11,582
0.0244%
$106.32$1.23M-40.03%
2021-12-14SaleSTAAR Surgical Company
STAA
Chief Technology Officer
6,000
0.0123%
$89.57$537,420-20.73%
2021-05-10SaleSTAAR Surgical Company
STAA
Chief Technology Officer
8,874
0.0213%
$125.83$1.12M+1.44%
2021-03-01SaleSTAAR Surgical Company
STAA
Chief Technology Officer
18,991
0.04%
$104.55$1.99M+10.47%
2020-11-09SaleSTAAR Surgical Company
STAA
Chief Technology Officer
23,714
0.0524%
$81.56$1.93M+48.29%
2020-09-15SaleSTAAR Surgical Company
STAA
Chief Technology Officer
36,326
0.0798%
$53.33$1.94M+108.87%
2020-09-14SaleSTAAR Surgical Company
STAA
Chief Technology Officer
35,689
0.0783%
$53.32$1.9M+107.8%
2020-05-15SaleSTAAR Surgical Company
STAA
Chief Technology Officer
25,000
0.0549%
$37.69$942,250+97.28%
2019-11-05SaleSTAAR Surgical Company
STAA
Chief Technology Officer
14,441
0.0315%
$35.00$505,435+8.46%
2019-11-04SaleSTAAR Surgical Company
STAA
Chief Technology Officer
2,100
0.0047%
$35.00$73,500+11.11%
2019-03-22SaleSTAAR Surgical Company
STAA
Chief Technology Officer
3,125
0.0073%
$38.89$121,531-16.7%
2019-03-19SaleSTAAR Surgical Company
STAA
Chief Technology Officer
2,084
0.0046%
$36.22$75,482-15.08%
2018-03-22SaleSTAAR Surgical Company
STAA
Chief Technology Officer
2,188
0.0053%
$16.03$35,065+119.07%
2018-03-20SaleSTAAR Surgical Company
STAA
Chief Technology Officer
1,458
0.0035%
$16.05$23,401+115.08%
2017-11-21SaleSTAAR Surgical Company
STAA
V.P., Chief Technology Officer
6,000
0.0145%
$16.65$99,915+66.77%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.